Sunday, December 8, 2019

Can a Netflix-style pricing model make medical treatments affordable for all?


According to a 2019 Gallup poll, 48% of Americans have a negative view of the American healthcare system compared to just 38% of Americans who have a positive view. These views have been rather steady since 2012. There’s little disagreement that the system is ill and something should be done to heal it; however, there are plenty of disagreements about the diagnosis of the illness and what kind of prescription is necessary. Jean-Manuel Izaret believes the needed prescription is to change the pricing model that’s used for pharmaceutical drugs. In his fifteen-minute Ted Talk presentation, he explains how he believes that a new Netflix-style pricing model could make treatments affordable for all over time.

Today, the American healthcare system uses a price per patient pricing model. That is, the system looks at how many patients are ‘ill enough’ today and need a pharmaceutical drug for treatment now. Jean makes the argument that this type of model not only fails to treat a large percentage of patients, but it’s also more expensive. Alternatively, he recommends the Netflix Pricing Model. In this model, healthcare providers will purchase pharmaceutical drugs through a subscription like Netflix. Doing so will not only treat more patients before their illness becomes more severe, but it will also save more money down the road.

Throughout his presentation, Jean uses many graphs that help show the current pricing model as well as the new model he’s proposing. Though I think the overall presentation was a little rushed given the nitty gritty details that are involved with economic models such as these, I still think Jean’s presentation was focused and engaging. Given the seriousness of the subject matter his tone was mainly serious, but there was some comic relief when he used the film industry as a comparison with how the current healthcare system operates. Personally, I look forward to the possibility of Jean-Manuel Izaret’s pricing model idea gathering some interest and being investigated further.